This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentumlast week, the FDA added Orforglipron and Wegovy to the Commissioners National Priority Voucher (CNPV) program, growing the initiative to a total of 15 products that tackle public health and national security priorities
More than half (53%) of people taking GLP-1 medications stop treatment within a year, according to a December 2025 Sermo survey of physicians who were asked how long their GLP-1 patients remain on therapy
Poly (2-oxazoline) hydrogels crosslinked with aliphatic bis (2oxazoline) s: Properties, cytotoxicity, and cell cultivation
Aliskiren, the first orally bioactive DRI, has been predicted to have greater potential for suppression of RAAS than any other class of drug
Peptides : Tighten the skin and reduce the appearance of wrinkles
Our team has found that this combined approach, available in preparations like our CJC-1295 / Ipamorelin blend, is the gold standard in research for maximizing the endogenous GH and, consequently, the IGF-1 response